New Triple-Threat attack on advanced kidney cancer before surgery
NCT ID NCT07172386
Summary
This study is testing a three-part treatment given before surgery for advanced kidney cancer. The goal is to shrink the tumor and make it easier to remove completely. The treatment involves a procedure to block the tumor's blood supply, followed by immunotherapy and targeted drug therapy. Researchers want to see if this approach is safe and helps patients have more successful surgery and better long-term results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA (RCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University Second Hospital
RECRUITINGTianjin, Tianjin Municipality, 300211, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.